ES8800266A1 - Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original - Google Patents

Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original

Info

Publication number
ES8800266A1
ES8800266A1 ES557188A ES557188A ES8800266A1 ES 8800266 A1 ES8800266 A1 ES 8800266A1 ES 557188 A ES557188 A ES 557188A ES 557188 A ES557188 A ES 557188A ES 8800266 A1 ES8800266 A1 ES 8800266A1
Authority
ES
Spain
Prior art keywords
peptides
proteins
amino acid
methods
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557188A
Other languages
English (en)
Other versions
ES557188A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by University of Texas System filed Critical University of Texas System
Publication of ES8800266A1 publication Critical patent/ES8800266A1/es
Publication of ES557188A0 publication Critical patent/ES557188A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

METODO DE OBTENER UN POLIPEPTIDO COMPLEMENTARIO DE AL MENOS UNA PORCION DE UN PEPTIDO O PROTEINA ORIGINAL. COMPRENDE: A) DETERMINAR UNA SECUENCIA DE AMINOACIDOS DE UNA PORCION DEL PEPTIDO; B) EMPLEAR UN AMINOACIDO DEL GRUPO (A) EN VEZ DE AMINOACIDO DEL GRUPO U; C) UTILIZAR UN AMINOACIDO DEL GRUPO U EN VEZ DEL AMINOACIDO DEL GRUPO (A); D) SUSTITUIR EL AMINOACIDO DEL GRUPO C POR UN AMINOACIDO DEL GRUPO (G); E) EMPLEAR EN LUGAR DE CADA AMINOACIDO DEL GRUPO (G) UN AMINOACIDO DEL GRUPO (C); F) INSERTAR UNA SECUENCIA DE NUCLEOTIDOS DE ADN QUE INCLUYE EL CODIGO DEL POLIPEPTIDO EN UN PLASMIDO PARA FORMAR UN VECTOR RECOMBINANTE; Y G) TRANSFORMAR UN ORGANISMO CELULAR (CELULAS DE LEVADURA) QUE BIOSINTETIZA AL POLIPEPTIDO PARA FORMAR UN POLIPEPTIDO. SE UTILIZA PARA TRATAR LA DIABETES.
ES557188A 1985-03-01 1986-11-03 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original Expired ES8800266A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (2)

Publication Number Publication Date
ES8800266A1 true ES8800266A1 (es) 1987-11-01
ES557188A0 ES557188A0 (es) 1987-11-01

Family

ID=27108003

Family Applications (3)

Application Number Title Priority Date Filing Date
ES552534A Expired ES8705919A1 (es) 1985-03-01 1986-02-28 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES557188A Expired ES8800266A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
ES557189A Expired ES8800267A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES552534A Expired ES8705919A1 (es) 1985-03-01 1986-02-28 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557189A Expired ES8800267A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor

Country Status (18)

Country Link
US (2) US5077195A (es)
EP (2) EP0214232B1 (es)
JP (1) JPH07215999A (es)
KR (1) KR920002315B1 (es)
AT (2) ATE88572T1 (es)
AU (1) AU592781B2 (es)
BR (1) BR8606615A (es)
CA (1) CA1339606C (es)
DE (2) DE3679017D1 (es)
DK (1) DK521386A (es)
ES (3) ES8705919A1 (es)
FI (1) FI90255C (es)
GR (1) GR860576B (es)
IE (1) IE58837B1 (es)
IL (1) IL96043A0 (es)
NO (1) NO174971C (es)
PT (1) PT82132B (es)
WO (1) WO1986005208A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592324B2 (en) * 1984-10-29 1990-01-11 Roche Diagnostics Corporation Mehods for protein binding enzyme complementation assays
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
AU595597B2 (en) * 1986-02-19 1990-04-05 Triton Biosciences Inc. Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
DK105289A (da) * 1988-03-04 1989-09-05 Univ Alabama Peptidaekvivalenter til ikke-peptider og fremgangsmaader til udformning af disse
DE69033395D1 (de) * 1989-07-31 2000-01-20 Tecnogen Scpa Verfahren zur Identifizierung und Herstellung von Bindungsstellen aufeinanderwirkender Proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
JP3923515B2 (ja) * 1993-10-07 2007-06-06 倉敷紡績株式会社 エンドセリン活性抑制剤
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
EP0835446B1 (en) 1995-06-26 2003-04-09 Perseptive Biosystems, Inc. High speed, automated, continuous flow, multi-dimensional molecular selection and analysis
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
DE69829995T2 (de) * 1997-12-01 2006-02-23 Fang, Fang, San Diego Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
CA2350163A1 (en) * 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
ATE411811T1 (de) * 1999-03-09 2008-11-15 Fornix Biosciences N V Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie
GB2356401A (en) * 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
AU2001294822A1 (en) * 2000-09-26 2002-04-08 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
DE60238308D1 (de) * 2001-02-20 2010-12-30 Univ Georgia Schnellproduktion monoklonaler antikörper
CA2898314A1 (en) * 2001-07-19 2003-07-31 Perian Therapeutics, Inc. Multimeric proteins and methods of making and using same
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
MX2009013628A (es) * 2007-06-14 2010-02-22 Univ Oklahoma State Vacunas que contienen variantes geneticas de parvovirus canino.
US20190062373A1 (en) * 2017-08-30 2019-02-28 Peption, LLC Method of generating interacting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
KR920002315B1 (ko) 1992-03-21
IE860527L (en) 1986-09-01
ES8800267A1 (es) 1987-11-01
DE3688333D1 (de) 1993-05-27
KR870700100A (ko) 1987-02-28
DE3688333T2 (de) 1993-10-28
EP0332225A3 (en) 1989-09-27
FI90255B (fi) 1993-09-30
AU592781B2 (en) 1990-01-25
PT82132A (en) 1986-04-01
FI864427A (fi) 1986-10-30
AU5510286A (en) 1986-09-24
JPH07215999A (ja) 1995-08-15
GR860576B (en) 1986-07-01
WO1986005208A1 (en) 1986-09-12
DK521386A (da) 1986-12-29
FI90255C (fi) 1994-01-10
DK521386D0 (da) 1986-10-31
IL96043A0 (en) 1991-07-18
US5212072A (en) 1993-05-18
ATE63138T1 (de) 1991-05-15
BR8606615A (pt) 1987-08-11
NO174971C (no) 1994-08-10
FI864427A0 (fi) 1986-10-30
PT82132B (pt) 1989-05-31
EP0332225B1 (en) 1993-04-21
CA1339606C (en) 1997-12-30
EP0332225A2 (en) 1989-09-13
US5077195A (en) 1991-12-31
DE3679017D1 (de) 1991-06-06
NO174971B (no) 1994-05-02
ES8705919A1 (es) 1987-05-16
ES557189A0 (es) 1987-11-01
EP0214232B1 (en) 1991-05-02
EP0214232A1 (en) 1987-03-18
IE58837B1 (en) 1993-11-17
ES557188A0 (es) 1987-11-01
ATE88572T1 (de) 1993-05-15
NO864369D0 (no) 1986-10-31
ES552534A0 (es) 1987-05-16
NO864369L (no) 1987-01-02

Similar Documents

Publication Publication Date Title
ES8800266A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
ES2009590A6 (es) Metodo de preparacion de proteina de cadena pesada del factor tisular humano.
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
HK1041497A1 (en) Soluble receptor br43x2 and methods of using them for therapy
EP0150735A3 (en) Method and composition for preparation of factor viiic
ATE189684T1 (de) Rekombinante polypeptide und peptide, dafür kodierende nukleinsäuren und ihre verwendung in der tuberkulose-diagnose
ZA861482B (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
Maloy et al. Amino acid sequence of the biotinyl subunit from transcarboxylase.
GR3035099T3 (en) Corpuscles of stannius protein, stanniocalcin
Goto et al. Structural studies on stem bromelain isolation, characterization and alignment of the cyanogen bromide fragments
Fisher et al. Affinity labelling of the binding site of rabbit antibody. Evidence for the involvement of the hypervariable regions of the heavy chain
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
Barnett et al. Biological Sciences: Amino-acid Sequence of the Carboxyl Terminal Octapeptide of Human Haptoglobin β Chain
Roholt et al. A light chain tyrosyl sequence in the antibody site of a rabbit anti-p-azobenzoate antibody
Carrel et al. Studies on sheep anti-human IgG antibodies and their sub-units
IL96043A (en) Polypeptides having binding affinity for peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known,the binding affinity being dependent on the carboxy-terminal and amino-terminal directionality of the polypeptides
NZ606260A (en) Novel polypeptides involved in immune response

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980504